Physician profile
Michelle Kerr
NPI 1881774164
$7,460.52
in general payments reported to CMS, 2019-2025
28 companies · $1,121 in 2025
The $1,121 reported for 2025 was more than what 92% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $997 · 2020: $355 · 2021: $1,091 · 2022: $605 · 2023: $2,240 · 2024: $1,052 · 2025: $1,121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,271 · Travel and Lodging: $1,142.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,271.21 |
| Travel and Lodging | $1,141.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $1,818.25 | 2019-2024 | |
| Johnson & Johnson Vision Care, INC. | $719.78 | 2019-2025 | Acuvue |
| Abbvie INC. | $719.71 | 2022-2025 | |
| Alcon Vision LLC | $672.34 | 2019-2025 | Rocklatan, Precision7, Total30 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $585.96 | 2019-2021 | |
| Tarsus Pharmaceuticals, INC. | $448.29 | 2024-2025 | Xdemvy |
| Coopervision INC. | $386.38 | 2021-2025 | Myday Contact Lens, Misight Contact Lens, Paragon Crt |
| Aerie Pharmaceuticals, INC. | $278.22 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $273.78 | 2019-2025 | Eylea Hd, Eylea |
| Dompe US, INC. | $219.19 | 2019-2024 | Oxervate |
| Allergan, INC. | $191.58 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $155.97 | 2019-2023 | Cequa |
| Glaukos Corporation | $155.92 | 2020-2025 | Idosetr, Photrexa Viscous and Photrexa, Kxl System (Not Refurbished) |
| Genentech USA, INC. | $144.09 | 2023-2025 | Vabysmo |
| Mallinckrodt Hospital Products INC. | $143.90 | 2021-2023 | Acthar |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $130.49 | 2022-2025 | Tearcare System, Omni Surgical System |
| Lkc Technologies, INC. | $84.05 | 2025 | |
| Visioneering Technologies, INC. | $68.10 | 2019 | |
| Carl Zeiss Meditec, INC. | $44.34 | 2020 | |
| Oyster Point Pharma, INC. | $37.34 | 2022-2023 | Tyrvaya |
| Rayner Intraocular Lenses Limited | $30.64 | 2025 | Omidria |
| Rxsight INC | $27.04 | 2025 | Rxsight Contact Lens, Light Adjustable Lens (Lal), Rxsight Injector Cartridge |
| Harrow Eye, LLC | $25.38 | 2024 | Vevye |
| Optos, INC. | $25.00 | 2021 | |
| Kala Pharmaceuticals, INC. | $23.78 | 2021 | |
| Alcon Research LLC | $18.59 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $18.00 | 2023 | Tecnis Iol, Tecnis Iol |
| Bausch & Lomb Americas INC. | $14.41 | 2025 | Miebo, Xiidra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Kerr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.